Smartleaf Asset Management’s Pulse Biosciences PLSE Stock Holding History

Smartleaf Asset Management’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.65K	Buy	+111	New	+$4.68K	﹤0.01%	2666

Other funds holding PLSE

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $116B AUM 33.19% 1-Year Est. Return

Smartleaf Asset Management's PLSE Position: Q3 2026 in Review

Smartleaf Asset Management opened a new position in Pulse Biosciences (PLSE) in Q3 2026: 111 shares worth $5.65K. The stake represents ﹤0.01% of the portfolio and ranks #2666 among its holdings.

97 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.

Smartleaf Asset Management held 111 shares of Pulse Biosciences worth $5.65K as of Q3 2026.
Pulse Biosciences was a new Smartleaf Asset Management position in Q3 2026.
Pulse Biosciences made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #2666 holding.
97 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.